We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$20.1B
AUM Growth
+$3.5B
Cap. Flow
+$2.5B
Cap. Flow %
12.41%
Top 10 Hldgs %
33.13%
Holding
257
New
120
Increased
40
Reduced
39
Closed
20

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$546M
2
WTW icon
Willis Towers Watson
WTW
+$471M
3
MA icon
Mastercard
MA
+$344M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$240M
5
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$238M

Top Sells

Rank Stock Value
1
TIF
Tiffany & Co.
TIF
+$301M
2
NYT icon
New York Times
NYT
+$209M
3
V icon
Visa
V
+$194M
4
ELV icon
Elevance Health
ELV
+$145M
5
ABBV icon
AbbVie
ABBV
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 35.71%
2 Technology 14.95%
3 Financials 13.65%
4 Communication Services 11.15%
5 Industrials 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSQD.U
176
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$5M 0.02%
+500,000
New +$5.19M
HERAU
177
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$5M 0.02%
+500,000
New +$5.02M
LCAHU
178
DELISTED
Landcadia Holdings IV, Inc. Units
LCAHU
$4.95M 0.02%
+500,000
New +$4.96M
CLAA.U
179
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$4.92M 0.02%
+500,000
New +$4.98M
EQ icon
180
Equillium
EQ
$146M
$4.86M 0.02%
680,000
-20,000
-3% -$143K
SCOBU
181
DELISTED
ScION Tech Growth II Units
SCOBU
$4.48M 0.02%
+450,000
New +$4.62M
NDACU
182
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
$4.08M 0.02%
+400,000
New +$4.08M
HMCO
183
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$4.07M 0.02%
+408,900
New +$4.26M
CCVI.U
184
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$4.02M 0.02%
+400,000
New +$4.33M
FRSGU
185
DELISTED
First Reserve Sustainable Growth Corp. Unit
FRSGU
$4.01M 0.02%
+400,000
New +$4.01M
GIIXU
186
DELISTED
Gores Holdings VIII, Inc. Unit
GIIXU
$4M 0.02%
+400,000
New +$4.06M
IPVA.U
187
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
$3.96M 0.02%
+400,000
New +$3.99M
AFMD
188
DELISTED
Affimed
AFMD
$3.96M 0.02%
+50,000
New +$3.25M
KURIU
189
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
$3.95M 0.02%
+400,000
New +$4.08M
VPCC.U
190
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
$3.95M 0.02%
+400,000
New +$3.99M
IPVF.U
191
DELISTED
InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVF.U
$3.94M 0.02%
+400,000
New +$3.99M
CMIIU
192
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$3.2M 0.02%
+250,000
New +$3.14M
LGV.U
193
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$3.06M 0.02%
+304,698
New +$3.06M
LGACU
194
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$3M 0.01%
+300,000
New +$3.05M
SGFY
195
DELISTED
Signify Health, Inc.
SGFY
$2.93M 0.01%
+100,000
New +$3.09M
EMBK
196
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$2.76M 0.01%
+13,901
New +$2.77M
SVFA
197
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$2.55M 0.01%
+250,000
New +$2.95M
DGNU
198
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$2.53M 0.01%
+250,000
New +$2.52M
ACRS icon
199
Aclaris Therapeutics
ACRS
$944M
$2.52M 0.01%
+100,000
New +$1.96M
GTPAU
200
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$2.51M 0.01%
+250,000
New +$2.54M
6 7
8
9 10

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2021 Portfolio in Review

As of Q1 2021, Thomas Steyer held 257 positions worth $20.1B, up 21% from $16.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Thomas Steyer deployed $2.5B of net new capital in Q1 2021, opening 120 new positions and adding to 40 existing holdings. Its largest new stake was Mastercard: 985,920 shares worth $351M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was New York Times, an estimated $209M trimmed.

  • Thomas Steyer's largest Q1 2021 buy was Mastercard: 985,920 shares worth $351M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q1 2021, an estimated $546M increase.
  • Thomas Steyer's biggest Q1 2021 reduction was New York Times, cutting an estimated $209M.
  • Thomas Steyer fully exited Tiffany & Co. in Q1 2021, selling an estimated $301M.
  • Thomas Steyer's ten largest holdings make up 33% of its $20.1B portfolio in Q1 2021.
  • Thomas Steyer opened 120 new positions and closed 20 in Q1 2021.
  • Thomas Steyer's portfolio value rose 21% quarter-over-quarter to $20.1B.

Based on Farallon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.